Rize, Inc.

Woburn,  MA 
United States
  • Booth: 1010

Rize is transforming how products are designed and manufactured with our patented and versatile APD (Augmented Polymer Deposition) technology that provides the industry's fastest turnaround on manufacturing parts, enabling you to iterate faster than with any other 3D printing technology, improve designs and exponentially speed your entire R&D process.

Our deeply experienced team of former Z Corporation, Objet and Revit materials, hardware and software experts, with over 20 patents, is fulfilling an unmet need for a fast, affordable and office-safe industrial 3D printing platform that can be used successfully across a wide variety of commercial applications, including prototypes, tooling, fixtures and jigs and customized end-use parts.

We are dedicated to putting an entirely fast, safe and affordable industrial-class 3D printer, capable of producing injection molded-quality parts, in every engineer’s office. 

 Press Releases

  • The only zero-post-processing 3D printer, Rize One reduces turnaround time by 50%, cuts costs, improves part strength and eliminates harmful materials

    WOBURN, Mass. (July 20, 2016) – Rize Inc., today emerged from stealth mode with a technology breakthrough that redefines 3D printing standards for industrial desktop machines. The first zero post-processing 3D printer, Rize One reduces turnaround time by 50%, cuts costs, improves part strength and eliminates the need for materials, equipment, facilities and mess that have been obstacles to expanding usage of desktop machines out of dedicated lab environments.

    Backed by Longworth Venture Partners and SB Capital with $4M in seed funding, Rize One is currently entering beta with Reebok. It will be available later this year.

    For years, 3D printing technology has forced designers and engineers to make sacrifices around time and resources to turn a printed part into a usable one. With Rize One, featuring a patented Augmented Polymer Deposition (APD™) process and RiziumÔ One, Rize’s unique engineering- and medical-grade thermoplastic filament, users simply release a 3D printed part from its support structure cleanly, safely and in seconds with bare hands. No filing or sanding are required.

    “Post-processing has been 3D printing’s dirty little secret, as engineers and additive manufacturing lab managers wrestled with the reality that post-processing parts after 3D printing often doubled the total process time; added substantial costs; and prevented 3D printers from the desktop,” said Frank Marangell, President and CEO of Rize and former president of Objet North America. “Rize One eliminates those sacrifices, opening a world of possibilities for designers and engineers to deliver prototypes and on-demand finished parts much faster and with stronger material – than before. Whether 3D printing helps you go to market, or create a market, Rize will fundamentally alter your production cycle.”

    For those who depend upon prototyping to fuel innovation, or who see the potential for on-demand production parts, Rize One will fundamentally alter the process of delivering a finished part. An updated prototype for a critical meeting the next morning. An idea sent to an overseas desktop for evaluation that same day. A custom part printed and installed while a customer waits, or in time to keep an assembly line humming.

    “We run our 3D printers 24/7 to create the parts central to Reebok’s innovation, and, unfortunately, post processing has been a necessary but laborious and time-consuming process,” said Gary Rabinovitz, Additive Manufacturing Lab Manager at Reebok. “An easy-to-use, zero post-processing 3D printer like Rize would dramatically improve workflow, enabling us to deliver parts as much as 50% faster than similar technologies, while reducing the cost of labor, materials and equipment."

    Rize One was designed to be used primarily by engineers and product designers across a wide range of industrial and commercial applications, including prototyping for proof of concept and form, fit and functional testing in real-world conditions, end-use production parts and tooling, fixtures and jigs for manufacturing. Users will experience improved designs, increased accuracy of production, reduced defects during manufacturing, cost reduction, streamlined operations and faster time to market.

    The technology powering Rize One also is adaptable enough to allow for the use of other materials that have various part properties – creating a wider spectrum of applications.

    Rize has harnessed the expertise of a deeply experienced team of 3D printing materials, hardware and software professionals from Z Corporation, Objet and Revit with over 20 patents. That team is led by Marangell, who took Objet, in six years, from a garage-based startup in the U.S. to an $85M behemoth, setting up an acquisition by Stratasys. The Company was co-founded in by Eugene Giller, who developed inkjet 3D printing technology at Z Corporation and Leonid Raiz, inventor of 3D CAD software, architect of PTC’s Pro Engineer and founder of Revit.

    “With its experience and pedigree in the industry, Rize has put together a dream team,” said Nilanjana Bhowmik, Partner at Longworth Venture Partners. “This innovation will make a significant impact on the 3D printing industry.”

    Additional Resources

    About Rize Inc.

    Rize is unlocking 3D printing for new markets and driving the next wave of innovation and advancement in product design and manufacturing with patented APD (Augmented Polymer Deposition) technology that provides the only hassle-free, safe and affordable industrial-class 3D printing solution. Our deeply experienced team of former Z Corporation, Objet and Revit materials, hardware and software experts, with over 20 patents, is fulfilling an unmet need for a completely office-safe and affordable 3D printing platform that can be used successfully across a wide variety of commercial applications, including prototyping, production parts and tooling, fixtures and jigs. https://www.rize3d.com



    Julie Reece

    Vice President of Marketing

    Rize Inc.


    +1 978 699 3085, ext. 708


  • Rize One
    Rize One is the only versatile industrial 3D printer for your lab or office that enables you to do more iterations faster, improving designs and exponentially speeding your entire R&D process....

  • You need to do more iterations faster than ever to stay competitive. But post-processing adds hours and cost onto the 3D printing process, including

    • 17 - 100% increase in total process time
    • 1:1 - 1:3 total head count (ratio of machine operators to part finishers)
    • One-half to one square foot for post-processing for each square foot of 3D printer space, plus equipment and utilities
    • $100K - $500K per year in staffing expense
    • $25K - $50K per year, per 3D printer
    • 60% 3D printer utilization rate due to post-processing bottlenecks
    • Capability limitations due to staffing
    • Peak demand requires added cost to outsource
    • Part quality is compromised
    • Health and mess concerns prohibit office use

    Rize One, the only zero-post-processing 3D printer, lets you produce parts up to 100% faster than other systems, exponentially speeding your entire R&D process. Gone are the messy and toxic post-processing materials, the special hookups and space required for post-processing devices and disposal and the hours of expensive labor required to deal with all of it. Finally, you can produce industrial-class parts in the lab or on demand, right in your office, quickly, safely and affordably.

 Additional Info

MMI: Take this opportunity to tell us how you support the use of additive manufacturing in medicine.
Rize is the only safe, bio-compatible, professional desktop 3D printer, suitable for a medical office. Turn CT scan data into replicas of bones or organs for a pre-surgical meeting while you wait, make a tool or prototype for a medical device in a few hours. Rize 3D printers produce prototypes to improve device design, functional parts for appliance testing, end-use parts for clinical trials and customized prosthetics, and accurate models for pre-surgical planning and clinical education.